Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice
about
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesEndocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axisEndogenous lipid activated G protein-coupled receptors: emerging structural features from crystallography and molecular dynamics simulationsSpice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoidsModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionSex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?Amygdala FAAH and anandamide: mediating protection and recovery from stressTime-Dependent Protection of CB2 Receptor Agonist in StrokeEffects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in miceGenetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors.Expression Analysis of CB2-GFP BAC Transgenic MiceEarly Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in ratsCannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the HippocampusInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionEffects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seekingDistinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?Endocannabinoid signalling in reward and addiction.CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory.Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotineDesign, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse.Behavioral effects of cocaine mediated by nitric oxide-GAPDH transcriptional signaling.Cocaine-induced behavioral sensitization is associated with changes in the expression of endocannabinoid and glutamatergic signaling systems in the mouse prefrontal cortex.Endocannabinoids and striatal function: implications for addiction-related behavioursTargeted zwitterionic near infrared fluorescent probe for improved imaging of type 2 cannabinoid receptors.Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats.Endogenous cannabinoid signaling at inhibitory interneurons.The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspectiveGlobal fold of human cannabinoid type 2 receptor probed by solid-state 13C-, 15N-MAS NMR and molecular dynamics simulations.Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodentsAM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in miceMultiple functions of endocannabinoid signaling in the brain.The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence.Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms.Endocannabinoid signaling and synaptic function.Increased vulnerability to cocaine in mice lacking dopamine D3 receptorsCannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal
P2860
Q24623282-8E53F535-67D9-4B93-BDB4-F7F0EBF86161Q26991850-7B8375F1-4F96-4AD3-9922-088E04735BA2Q27009220-A2E9E2E8-21C2-4841-B304-2A223E71DCFFQ27010555-CE1184B8-0E36-4A43-AE5F-2C305A0017C8Q27014154-1CEF585B-2B19-4E08-9114-ADC8095E25F8Q27015088-CBEE4617-8D01-47F5-89A9-7CE3B81EDCC5Q27026443-2DE84E55-4035-43AE-88BB-B5C931E58656Q27302924-0C593E89-46E4-45F3-8F7E-F74ECA614839Q27312372-FFBC2BB3-5F3D-40E3-B581-8E7739CD1F81Q27315226-EEE9A06D-C809-4DA5-98CA-D524F4565D2AQ27316448-58ABDF2A-FC93-4EA9-BC5F-CC396EB5469AQ27336497-E34C0596-7E09-4B4C-895D-30AF557BA46CQ28272826-C462FBBD-8C0C-4E74-A507-0E8813FBAE64Q28275230-D797B911-CAE3-49F4-876B-B436FCB54E2BQ28283718-61F29188-C478-4123-BA2D-00BE7AB10879Q28480387-CDA20CF6-4428-42D5-AE2F-74145ADA73CAQ28540537-64C7DF56-B26C-4372-BBB6-D703E8940859Q30373359-BE6E7C46-BF24-4D0D-8980-D97B48483A5AQ30392902-736481DE-F8B2-461A-92FD-571EC576BA3AQ30551483-B388B1B7-770F-487A-B910-5B5344190241Q30569742-F559C99C-AAF4-43CA-B139-37B848F38173Q30580057-26DA4BCF-3130-4E65-AD49-24363C3E5455Q30630783-CBA2942C-FE3A-4226-9143-E5DF914AC236Q33583792-66F5A277-C04D-4567-9E78-ADC099BD9DBCQ33604098-351A3A75-D470-4CB4-A97E-DF72090DA0B8Q33614204-ACC287C7-DE25-495A-B376-C6C20198B5FCQ33624983-2BAF1EB2-297F-4F27-8F06-9D43F4F107FAQ33703839-A34B6C1E-3733-45AE-9B72-076AD48FAF31Q33781776-773D4542-4FEC-4813-A19D-70D3DF5301E1Q33809669-4DAA667C-9335-48E3-99E2-B57E3038FCDBQ33819365-D16461FA-052C-4703-9BAA-84D1E33612A6Q33948790-655244F9-BDF6-46E2-AC21-24CD74C174CAQ34223229-E5059ED0-0ADE-49DD-B0E2-01F9AAC2159CQ34270199-4AE828A6-3274-41B9-A6A7-A8C42261D4E8Q34282073-FC8A559F-45FF-4988-B0C6-4738502F2C39Q34302209-3CEEA918-5417-4754-9365-5A08DD5E5A16Q34304094-21B80094-4656-419B-891C-534FC2C475B7Q34304643-DA83536F-A3DA-4C28-845D-3B72AF279D1AQ34311721-875BD621-B310-4614-A7D1-3985D9C654E5Q34403197-2D64F165-B098-4585-8CB3-86810CCD93E1
P2860
Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice
@ast
Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice
@en
Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice
@nl
type
label
Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice
@ast
Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice
@en
Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice
@nl
prefLabel
Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice
@ast
Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice
@en
Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice
@en
P2093
Eliot L Gardner
Guo-Hua Bi
Hong-Ju Yang
Zheng-Xiong Xi
P2860
P2888
P304
P356
10.1038/NN.2874
P407
P577
2011-07-24T00:00:00Z